Taysha Gene Therapies (TSHA) Other Gross PP&E Adjustments (2022 - 2025)
Historic Other Gross PP&E Adjustments for Taysha Gene Therapies (TSHA) over the last 4 years, with Q3 2025 value amounting to $3.2 million.
- Taysha Gene Therapies' Other Gross PP&E Adjustments rose 4352.89% to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.2 million, marking a year-over-year increase of 4352.89%. This contributed to the annual value of $2.0 million for FY2024, which is 4957.62% down from last year.
- Latest data reveals that Taysha Gene Therapies reported Other Gross PP&E Adjustments of $3.2 million as of Q3 2025, which was up 4352.89% from $2.0 million recorded in Q2 2025.
- In the past 5 years, Taysha Gene Therapies' Other Gross PP&E Adjustments registered a high of $5.5 million during Q2 2023, and its lowest value of $1.4 million during Q1 2025.
- In the last 4 years, Taysha Gene Therapies' Other Gross PP&E Adjustments had a median value of $3.9 million in 2023 and averaged $3.8 million.
- Examining YoY changes over the last 5 years, Taysha Gene Therapies' Other Gross PP&E Adjustments showed a top increase of 4352.89% in 2025 and a maximum decrease of 6241.27% in 2025.
- Over the past 4 years, Taysha Gene Therapies' Other Gross PP&E Adjustments (Quarter) stood at $5.3 million in 2022, then fell by 26.16% to $3.9 million in 2023, then plummeted by 49.58% to $2.0 million in 2024, then soared by 63.27% to $3.2 million in 2025.
- Its Other Gross PP&E Adjustments stands at $3.2 million for Q3 2025, versus $2.0 million for Q2 2025 and $1.4 million for Q1 2025.